Skip to content

Evaluation of the Efficacy and Safety of Herbal Medicine for Treating Work-related Chronic Low Back Pain

Evaluation of the Efficacy and Safety of Herbal Medicine for Treating Work-related Chronic Low Back Pain: a Multicenter, Randomized, Controlled, Clinical Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02988232
Acronym
WRMD
Enrollment
72
Registered
2016-12-09
Start date
2016-07-01
Completion date
2020-12-30
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain, Workplace

Keywords

Work Related Chronic Low Back Pain, Korean Medicine, Sogyeonghwalhyeol-tang

Brief summary

The Purpose of this trial is to investigate the efficacy and safety of Sogyeonghwalhyeol-tang(SGHH) on Korean Patients With Work Related Chronic Low Back Pain

Detailed description

Investigating the efficacy and safety of Sogyeonghwalhyeol-tang(SGHH) on Korean Patients With Work-related Chronic Low Back Pain

Interventions

DRUGSogyeonghwalhyeol-tang

herbal extract

DRUGPlacebo

extract powder with same appearance, odor and color as SGHH

Sponsors

Sangji University Oriental Medical Center, Korea
CollaboratorUNKNOWN
Semyung University Korean Medicine Hospital in Chungju, Korea
CollaboratorUNKNOWN
Daejeon University
CollaboratorOTHER
Gachon University Gil Oriental Medical Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Inpatients with chief complaint of low back pain in oriental rehabilitation medical center * Age 19 - 65 * Workplace Vulnerable populations(hospital workers, office worker, blue collar workers, transit workers) * Patients must include all of the following symptoms: * Those who have 4 \ 7 cm of VAS pain score; * Those who has classified as 'at risk non-complier' or 'pain complaints' by KOSHA questionnaire * Ability to have normal communication * Ability to give informed consent

Exclusion criteria

1. Patients with pain duration of 3 months or less 2. Patients with progressive neurologic deficit or severe neurologic symptoms by SLR test 3. Patients diagnosed with serious pathology(s) which may cause low back pain (e.g. spinal metastasis of tumor(s), acute fracture, etc) 4. Patients with spondylolisthesis or spondylolysis(diagnosed with grade II or higher level) 5. Patients currently taking steroids, immunosuppressants, medicine for mental illness or other medication(s) that may interfere with study results 6. Patients with history of spinal surgery 7. Patients with more severe pain than pain caused by low back pain 8. Those who do not (cannot) abide by treatment and follow up due to the mental illness such as behavior disorder, depression, anxiety neurosis etc. 9. Patients with history of Medical Malpractice Case 10. Patients with treatment history of low back pain within 1 month either KM or WM 11. Patients participating in other clinical studies within 3 months 12. Pregnant patients or patients with plans of pregnancy or lactating patients 13. Patients disagree to sign the informed consent form 14. Patients deemed unsuitable for participating the trial by the researchers

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in Numeric Rating Scale of PainScreening Visit, At baseline, week 2, 4, 6, 8A 10-point Numerical Pain Rating Scale (NPRS; 0: no pain, 10: maximum pain) assesses the patients' current level of pain.

Secondary

MeasureTime frameDescription
Change from Baseline in 'Roland Morris Disability Questionnaire'Screening Visit, At baseline, week 2, 4, 6, 8This is a self-reported questionnaire consisting of 24 items reflecting limitations in different activities of daily living attributed to low back pain including walking, bending over, sitting, lying down, dressing, sleeping, self-care and daily activities.
Change from Baseline in European Quality of life 5 DimensionScreening Visit, At baseline, week 2, 4, 6, 8The EQ-5D is an international, standardized, generic instrument for describing and valuing health status. Participants were asked to indicate which of the following statements best describes their health state.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026